Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage
June 11, 2024
June 11, 2024
June 6, 2024
June 5, 2024
May 29, 2024
May 29, 2024
May 22, 2024
May 15, 2024
May 15, 2024
May 15, 2024
April 8, 2025
Enlarged Leadership Team with CSO, Prof. Dr. Anton Wellstein, and CBO, Dr. Matthias Evers Indivumed is proud to announce major milestones achieved, ce...
April 3, 2025
Innovative Knowledge Discovery Platform to Accelerate Research into Promising Therapeutic Targets for Parkinson’s Disease ONTOFORCE, a leader in seman...
March 11, 2025
PHC Corporation of North America (PHCNA), supplier of the PHCbi brand of preservation and growth products in North America and Latin America, has laun...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225